$-0.49 EPS Expected for Egalet (EGLT); Eaton Vance Tax Advantaged Dividend Income Fund (EVT) Sentiment Is 1.13

April 15, 2018 - By Darrin Black

Egalet Corporation (NASDAQ:EGLT) Logo

Analysts expect Egalet Corporation (NASDAQ:EGLT) to report $-0.49 EPS on May, 9.They anticipate $0.53 EPS change or 51.96% from last quarter’s $-1.02 EPS. After having $-0.27 EPS previously, Egalet Corporation’s analysts see 81.48% EPS growth. The stock decreased 0.09% or $0.0006 during the last trading session, reaching $0.6433. About 306,135 shares traded. Egalet Corporation (NASDAQ:EGLT) has declined 87.31% since April 15, 2017 and is downtrending. It has underperformed by 98.86% the S&P500.

Eaton Vance Tax Advantaged Dividend Income Fund (EVT) investors sentiment decreased to 1.13 in 2017 Q4. It’s down -0.34, from 1.47 in 2017Q3. The ratio dropped, as 26 investment professionals opened new or increased stock positions, while 23 cut down and sold their stakes in Eaton Vance Tax Advantaged Dividend Income Fund. The investment professionals in our database now own: 7.47 million shares, down from 7.87 million shares in 2017Q3. Also, the number of investment professionals holding Eaton Vance Tax Advantaged Dividend Income Fund in top ten stock positions was flat from 1 to 1 for the same number . Sold All: 8 Reduced: 15 Increased: 16 New Position: 10.

Eaton Vance Tax-Advantaged Dividend Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The company has market cap of $1.63 billion. The fund invests in public equity markets across the globe. It has a 9.58 P/E ratio. It seeks to invest in stocks of companies operating across the diversified sectors.

Joel Isaacson & Co. Llc holds 3.36% of its portfolio in Eaton Vance Tax-Advantaged Dividend Income Fund for 832,962 shares. Penbrook Management Llc owns 29,047 shares or 0.61% of their US portfolio. Moreover, Stratos Wealth Partners Ltd. has 0.6% invested in the company for 578,211 shares. The California-based Hollencrest Capital Management has invested 0.2% in the stock. Wealthtrust Axiom Llc, a Pennsylvania-based fund reported 10,640 shares.

The stock increased 0.18% or $0.04 during the last trading session, reaching $22.44. About 78,954 shares traded. Eaton Vance Tax-Advantaged Dividend Income Fund (EVT) has risen 3.24% since April 15, 2017 and is uptrending. It has underperformed by 8.31% the S&P500.

Since January 1, 0001, it had 1 insider purchase, and 0 sales for $5,600 activity.

Investors sentiment decreased to 0.47 in Q4 2017. Its down 0.11, from 0.58 in 2017Q3. It worsened, as 13 investors sold Egalet Corporation shares while 17 reduced holdings. 6 funds opened positions while 8 raised stakes. 13.62 million shares or 32.80% less from 20.27 million shares in 2017Q3 were reported. Georgia-based Advisory Svcs Network Lc has invested 0% in Egalet Corporation (NASDAQ:EGLT). Raymond James Financial Advsr has 16,884 shares for 0% of their portfolio. Stifel Fincl Corporation holds 0% or 11,225 shares. Goldman Sachs Gp Inc holds 0% of its portfolio in Egalet Corporation (NASDAQ:EGLT) for 68,731 shares. Bridgeway Cap Management reported 0% of its portfolio in Egalet Corporation (NASDAQ:EGLT). Msd Prtn Lp owns 1.04 million shares or 0.05% of their US portfolio. Fmr Limited Liability Company has 0% invested in Egalet Corporation (NASDAQ:EGLT). Highland Cap Mngmt Lp holds 0.01% or 119,520 shares in its portfolio. Virtu Limited Liability Corp holds 11,259 shares or 0% of its portfolio. Bnp Paribas Arbitrage Sa has 0% invested in Egalet Corporation (NASDAQ:EGLT). New York-based D E Shaw And Incorporated has invested 0% in Egalet Corporation (NASDAQ:EGLT). The New York-based J Goldman Ltd Partnership has invested 0% in Egalet Corporation (NASDAQ:EGLT). 22,159 are owned by Janney Montgomery Scott Ltd Liability. The California-based Wells Fargo And Mn has invested 0% in Egalet Corporation (NASDAQ:EGLT). Renaissance Ltd Liability Corporation invested in 0% or 721,800 shares.

Egalet Corporation, a specialty pharmaceutical company, develops, makes, and commercializes treatments for patients with pain and other conditions. The company has market cap of $29.54 million. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic moderate to severe pain where an opioid is appropriate; and ARYMO ER, an extended-release morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It currently has negative earnings. The firm is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER.

Among 5 analysts covering Egalet Ltd (NASDAQ:EGLT), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Egalet Ltd had 14 analyst reports since November 4, 2015 according to SRatingsIntel. As per Monday, August 14, the company rating was maintained by Guggenheim. Cantor Fitzgerald maintained the stock with “Buy” rating in Wednesday, November 8 report. JMP Securities maintained the shares of EGLT in report on Friday, July 14 with “Market Outperform” rating. Cantor Fitzgerald maintained Egalet Corporation (NASDAQ:EGLT) on Tuesday, June 13 with “Buy” rating. The rating was maintained by Cantor Fitzgerald with “Buy” on Wednesday, June 7. The firm has “Buy” rating given on Wednesday, November 4 by Cantor Fitzgerald. Cantor Fitzgerald maintained it with “Buy” rating and $3.5 target in Monday, March 12 report. The rating was maintained by Cantor Fitzgerald on Monday, August 14 with “Buy”. On Thursday, November 9 the stock rating was downgraded by Gabelli to “Hold”. As per Thursday, June 1, the company rating was maintained by Cantor Fitzgerald.

Egalet Corporation (NASDAQ:EGLT) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>